(Q46499527)

English

Coordinated induction of iNOS-VEGF-KDR-eNOS after resveratrol consumption: a potential mechanism for resveratrol preconditioning of the heart

scientific article published in April 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15905131

Coordinated induction of iNOS-VEGF-KDR-eNOS after resveratrol consumption: a potential mechanism for resveratrol preconditioning of the heart (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15905131

1 reference

based on heuristic

inferred from title

Nilanjana Maulik

5

object named as

Nilanjana Maulik

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15905131

author name string

Samarjit Das

1

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15905131

Vijay K T Alagappan

2

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15905131

Debasis Bagchi

3

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15905131

Hari S Sharma

4

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15905131

Dipak K Das

6

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15905131

publication date

1 April 2005

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15905131

Vascular Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15905131

42

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15905131

5-6

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15905131

281-289

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15905131

Angiotensin II type 2 receptor inhibits vascular endothelial growth factor-induced migration and in vitro tube formation of human endothelial cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.013

7 January 2021

Resveratrol provides late-phase cardioprotection by means of a nitric oxide- and adenosine-mediated mechanism

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.013

7 January 2021

Induced cytoskeletal changes in bovine pulmonary artery endothelial cells by resveratrol and the accompanying modified responses to arterial shear stress

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.013

7 January 2021

Vasorelaxing activity of resveratrol and quercetin in isolated rat aorta.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.013

7 January 2021

Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.013

7 January 2021

Endogenous, local, vascular endothelial growth factor production in patients with chronic total coronary artery occlusions: further evidence for its role in angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.013

7 January 2021

Resveratrol activates membrane-bound guanylyl cyclase in coronary arterial smooth muscle: a novel signaling mechanism in support of coronary protection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.013

7 January 2021

L-arginine reduces endothelial inflammation and myocardial stunning during ischemia/reperfusion

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.013

7 January 2021

Activity in vitro of resveratrol on granulocyte and monocyte adhesion to endothelium

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.013

7 January 2021

Genetic targeting for cardiovascular therapeutics: are we near the summit or just beginning the climb?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.013

7 January 2021

Nitric oxide signaling in the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.013

7 January 2021

Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.013

7 January 2021

Resveratrol, a polyphenol found in wine, reduces ischemia reperfusion injury in rat kidneys

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.013

7 January 2021

Role of STAT3 in ischemic preconditioning

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.013

7 January 2021

Resveratrol reduction of infarct size in Long-Evans rats subjected to focal cerebral ischemia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.013

7 January 2021

Cardioprotective effect of resveratrol, a natural antioxidant derived from grapes.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.013

7 January 2021

Beneficial effects of astringinin, a resveratrol analogue, on the ischemia and reperfusion damage in rat heart

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.013

7 January 2021

Resveratrol protects myocardial ischemia-reperfusion injury through both NO-dependent and NO-independent mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.013

7 January 2021

Genetic augmentation of nitric oxide synthase increases the vascular generation of VEGF.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.013

7 January 2021

Resveratrol, a red wine polyphenol, protects spinal cord from ischemia-reperfusion injury

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.013

7 January 2021

Inhibition of oxidized low-density lipoprotein-induced apoptosis in endothelial cells by nitric oxide. Peroxyl radical scavenging as an antiapoptotic mechanism

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.013

7 January 2021

Enhanced bronchial expression of vascular endothelial growth factor and receptors (Flk-1 and Flt-1) in patients with chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.013

7 January 2021

The vascular endothelial growth factor receptor KDR activates multiple signal transduction pathways in porcine aortic endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.013

7 January 2021

Nitric oxide synthase modulates angiogenesis in response to tissue ischemia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.013

7 January 2021

The possible implication of trans-Resveratrol in the cardioprotective effects of long-term moderate wine consumption

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.013

7 January 2021

Occurrence of resveratrol and pterostilbene in age-old darakchasava, an ayurvedic medicine from India

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.013

7 January 2021

The red wine antioxidant resveratrol protects isolated rat hearts from ischemia reperfusion injury

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.013

7 January 2021

Myocardial protection by protykin, a novel extract of trans-resveratrol and emodin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.013

7 January 2021

Oxygen, oxidants, and antioxidants in wound healing: an emerging paradigm

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.013

7 January 2021

Vascular endothelial growth factor governs endothelial nitric-oxide synthase expression via a KDR/Flk-1 receptor and a protein kinase C signaling pathway

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.013

7 January 2021

Resveratrol, a polyphenolic phytoalexin present in red wine, enhances expression and activity of endothelial nitric oxide synthase.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.013

7 January 2021

Nitric oxide and angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.013

7 January 2021

Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.02.013

7 January 2021

Pharmacological preconditioning with resveratrol: role of nitric oxide

1 reference

3 January 2024

https://opencitations.net/index/api/v1/citations/10.1152/AJPHEART.01012.2001

Identifiers

10.1016/J.VPH.2005.02.013

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15905131

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15905131

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46499527&oldid=2114455878"